Literature DB >> 16551206

An assessment of the diagnosed prevalence of diseases in men 50 years of age or older.

Muta M Issa1, Thomas C Fenter, Libby Black, Amy L Grogg, Eric J Kruep.   

Abstract

OBJECTIVE: A lack of focus on certain men's health problems has led to significant morbidity and mortality in aging men. Managed care must begin to focus on the conditions that are most prevalent in this fast-growing population in an effort to improve the quality of care. To assist in achieving this goal, a naturalistic retrospective study assessing the prevalence of the 10 leading disorders in men older than the age of 50 was conducted, with an additional focus on men eligible for Medicare.
METHODS: Claims data were obtained from the Integrated Health Care Information Solutions National Managed Care Benchmark database (Waltham, Mass), that includes data from 30 health plans covering more than 25 million lives, and from the Centers for Medicare & Medicaid Services, representing men from a 5% random sample of Medicare-eligible patients. Men older than 50 years of age were included in the study. The prevalence of all diseases was determined in the 2003 calendar year for each population. Prevalence was calculated by dividing the number of diagnosed cases of a disease by the total person-time observations within the 2003 period.
RESULTS: The results indicate that cardiovascular (ie, coronary artery disease [CAD], hypertension, and arrhythmias), urological (ie, enlarged prostate and prostate cancer), and musculoskeletal disorders (ie, osteoarthritis and bursitis) comprise 70% of the 10 leading diseases. CAD and hypertension ranked first and second across all age categories, whereas enlarged prostate ranked fourth. In men older than 50, diabetes ranked third, whereas cataracts ranked third in Medicare-eligible men.
CONCLUSION: The diseases identified in this study have the potential to cause significant clinical and economic implications when poorly treated or undertreated. Therefore, there is a need to institute early treatment for these conditions before they progress and require more extensive and costly interventions.

Entities:  

Mesh:

Year:  2006        PMID: 16551206

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  17 in total

1.  Ahead of the curve.

Authors:  David B Nash
Journal:  Popul Health Manag       Date:  2013       Impact factor: 2.459

2.  The outcome of radical prostatectomy for patients with prostate cancer and acute urinary retention.

Authors:  Alfonso Fernandez; Stephen E Pautler
Journal:  J Robot Surg       Date:  2010-07-28

3.  Effect of an employer-sponsored health and wellness program on medical cost and utilization.

Authors:  Hangsheng Liu; Katherine M Harris; Sarah Weinberger; Seth Serxner; Soeren Mattke; Ellen Exum
Journal:  Popul Health Manag       Date:  2012-07-23       Impact factor: 2.459

4.  Increasing Urologic Care Ratios: Implications of Male Patient Care in Florida.

Authors:  Walker Talton; Hanna Lindner; Michael J Rovito
Journal:  Am J Mens Health       Date:  2016-08-15

5.  The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians.

Authors:  Neal Shore; Barrett Cowan
Journal:  Ther Adv Chronic Dis       Date:  2011-11       Impact factor: 5.091

6.  Effect of benign prostatic hyperplasia on the development of spine, hip, and wrist fractures.

Authors:  S C Yang; Y C Chiu; P H Liu; T J Hsieh; Y H Kao; Y K Tu
Journal:  Osteoporos Int       Date:  2019-01-31       Impact factor: 4.507

Review 7.  Dutasteride: a review of its use in the management of prostate disorders.

Authors:  Susan J Keam; Lesley J Scott
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Prevalence, risk factors and quality of life of Lower Urinary Tract Symptoms (LUTS) among men attending Primary Care slum clinics in Bangalore: A cross-sectional study.

Authors:  Priyesh Kant; Leeberk Raja Inbaraj; Nirupama Navamani Franklyn; Gift Norman
Journal:  J Family Med Prim Care       Date:  2021-07-02

9.  Hyaluronic Acid (HA) Viscosupplementation on Synovial Fluid Inflammation in Knee Osteoarthritis: A Pilot Study.

Authors:  Heather K Vincent; Susan S Percival; Bryan P Conrad; Amanda N Seay; Cindy Montero; Kevin R Vincent
Journal:  Open Orthop J       Date:  2013-09-20

10.  Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia: clinical utility of dutasteride and tamsulosin.

Authors:  Bob Djavan; Seyed Saeid Dianat; Amir Kazzazi
Journal:  Patient Relat Outcome Meas       Date:  2011-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.